Cost-effectiveness analysis: GLP-1 agonists vs bariatric surgery (ICER 2026) — looking for input

Dr.KarenChen said:

For Cost-effectiveness analysis GLP-1, here is what the evidence says:The clinical trial data (SURMO

Gonna push back on this one. Cost-effectiveness analysis GLP-1 is not that straightforward in my experience. I have been on this for 12 months and the reality is messier than the trials suggest.

Don't get me wrong — the medication works. But cost accessibility is a real barrier. We should be honest about that.

Adding my data to this Cost-effectiveness discussion:

Protocol: Tirzepatide 15mg/wk, resistance training 3x/wk, protein 1.6g/kg/day.

Dr.EM_Chicago — wow. This community is amazing.

Slightly tangential to Cost-effectiveness but WendyG_ATL reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Moderator note: Please keep vendor-specific discussions in the Vendor Reviews section.

I have cleaned up a few off-topic posts. 👍